HOW WELL DO YOU KNOW WORLDWIDE CLINICAL TRIALS?
If you’re developing therapies targeting Central Nervous System, Cardiovascular, Metabolic, Immune-Mediated Inflammatory Disorders, Oncology, or Rare Diseases, you’ve probably heard about Worldwide’s full-service, award-winning CRO capabilities. And most know that we offer Bioanalytical, Phase I-IV clinical trial, and Real-World Evidence services. But, there might be a few things about Worldwide you don’t know. Our team of expert clinicians and operations leaders look forward to meeting you and sharing more about what makes us uncommon on January 8th. Join us!
ABOUT WORLDWIDE CLINICAL TRIALS
Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From early phase and bioanalytical sciences through late phase, post-approval and real-world evidence, we provide world-class, full-service drug development services.
With infrastructure and talent spanning 60 countries, we execute predictable, successful studies with operational excellence across a range of therapeutic areas, including central nervous system, cardiovascular, metabolic, immune-mediated inflammatory disorders (IMID), oncology and rare diseases. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO. For more information, visit www.worldwide.com.